Wingate Wealth Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21M Buy
77,148
+3,313
+4% +$133K 1.41% 19
2026
Q1
$2.67M Hold
73,835
1.43% 17
2025
Q4
$2.84M Buy
73,835
+3,440
+5% +$129K 1.58% 15
2025
Q3
$2.55M Sell
70,395
-746
-1% -$26K 1.76% 15
2025
Q2
$2.44M Sell
71,141
-1,046
-1% -$33.2K 2.17% 11
2025
Q1
$2.26M Buy
72,187
+9,321
+15% +$304K 2.6% 8
2024
Q4
$2.01M Buy
+62,866
New +$2.04M 1.97% 12

Other funds holding QLTY

Wingate Wealth Advisors's QLTY Position: Q2 2026 in Review

Wingate Wealth Advisors increased its GMO US Quality ETF (QLTY) stake by 4.5% in Q2 2026, buying an estimated $133K and bringing the position to 77,148 shares worth $3.21M. The position accounts for 1.41% of the portfolio, ranked #19.

Wingate Wealth Advisors first reported a position in QLTY in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Wingate Wealth Advisors held 77,148 shares of GMO US Quality ETF worth $3.21M as of Q2 2026.
  • Wingate Wealth Advisors bought 3,313 GMO US Quality ETF shares in Q2 2026, an estimated $133K.
  • GMO US Quality ETF made up 1.41% of Wingate Wealth Advisors's portfolio in Q2 2026, its #19 holding.
  • Wingate Wealth Advisors first reported a position in GMO US Quality ETF in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Wingate Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.